申请人:Eli Lilly and Company
公开号:US04661505A1
公开(公告)日:1987-04-28
This invention provides novel alkane derivatives which are leukotriene antagonists, formulations of those derivatives, and a method of using those derivatives for the treatment of conditions characterized by an excessive release of leukotrienes.
这项发明提供了新颖的烷烃衍生物,这些衍生物是白三烯拮抗剂,同时提供了这些衍生物的配方以及利用这些衍生物治疗由白三烯过度释放引起的疾病的方法。